Viyash Scientific Ltd (VIYASH)
🎯 Key Takeaways
- Revenue grew 2.9% QoQ to ₹946 in Q1FY27.
- Market Cap
- ₹10,304
- P/E Ratio
- 38.6
- P/B Ratio
- 3.66
- ROE
- 7.5%
- ROCE
- 14.6%
- Debt/Equity
- 0.15
- Promoter
- 61.3%
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 850 | 858 | 920 | 946 |
| Operating Profit | 114 | 117 | 124 | 117 |
| OPM % | 13.4% | 13.6% | 13.5% | 12.3% |
| Net Profit | 73 | 49 | 66 | 79 |
| EPS | ₹1.28 | ₹0.89 | ₹1.20 | ₹1.51 |
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 50 | 50 | 87 | 50 |
| Reserves | 654 | 630 | 2,731 | 759 |
| Borrowings | 481 | 489 | 436 | 490 |
| Total Liabilities | 1,602 | 1,562 | 4,628 | 1,726 |
| Fixed Assets | 284 | 294 | 2,105 | 297 |
| Investments | 0 | 1 | 0 | 0 |
| Total Assets | 1,602 | 1,562 | 4,628 | 1,726 |
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2026 |
|---|---|
| Operating | +323 |
| Investing | -84 |
| Financing | -123 |
| Net Cash Flow | +115 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 52.3% | 61.4% | 61.3% | 61.3% |
| FII | 5.9% | 3.2% | 2.9% | 4.5% |
| DII | 12.9% | 7.4% | 8.0% | 3.8% |
| Public | 22.7% | 19.2% | 19.0% | 20.5% |
| # Shareholders | 1,44,085 | 1,34,194 | 1,27,446 | 1,28,367 |
⚖️ Peer Comparison — Pharmaceuticals
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| SUNPHARMA | 4.37 L Cr | 36.1 | 18.7% | — | 0.05 |
| DIVISLAB | 2.46 L Cr | 84.2 | 23.0% | — | 0.00 |
| TORNTPHARM | 1.83 L Cr | 76.6 | 15.1% | — | 1.76 |
| ZYDUSLIFE | 1.16 L Cr | 25.9 | 16.8% | — | 0.43 |
| CIPLA | 1.09 L Cr | 32.3 | 13.2% | — | 0.01 |
| LAURUSLABS | 1.07 L Cr | 97.8 | 20.8% | — | 0.45 |
| MANKIND | 1.03 L Cr | 50.6 | 13.9% | — | 0.38 |
| DRREDDY | 1.03 L Cr | 31.9 | 10.1% | — | 0.17 |
| AUROPHARMA | 95,887 | 26.0 | 12.8% | — | 0.20 |
| LUPIN | 93,367 | 16.5 | 27.9% | — | 0.26 |
🔗 Peer Stock Analyses
📋 Recent Filings
- Announcement2026-09-28Viyash Scientific Limited announced that its trading window will close on October 1, 2026, and remain shut for 48 hours after the unaudited quarterly …
- 🔴 Corporate Action2026-09-18Viyash Scientific announced the allotment of 11,07,309 equity shares under its ESOP 2020 and ESOP 2026 schemes on September 18, 2026, increasing paid-…
- 🔴 Announcement2026-09-08Viyash Scientific announced that Italian regulatory approval for its proposed acquisition of BioForLife Italia S.r.l. has been secured, accelerating t…
- 🔴 Corporate Action2026-09-04Viyash Scientific announced the allotment of 612,773 equity shares under its 2020 and 2026 employee stock option schemes, increasing paid-up capital f…
- 🔴 Insider Trading2026-08-27CA Harbor and CA Hull sold 2.48 million and 2.56 million shares of Viyash Scientific Ltd on August 26, 2026, reducing their combined stake to 24.47% a…
- Announcement2026-08-16Viyash Scientific reported robust Q1 FY27 results with 20% YoY revenue growth to Rs. 946 crores and 115% YoY PAT growth to Rs. 79 crores, driven by 59…
- 🔴 Financial Results2026-08-12Viyash Scientific reported Q1 FY27 standalone revenue of ₹9,464 million, up 19.5% YoY, with EBITDA at ₹2,047 million (+59.2% YoY) and net debt of ₹1,6…
- 🔴 Financial Results2026-08-12Viyash Scientific Limited announced the audio recording of its earnings call for the quarter ended June 30, 2026, held on August 12, 2026, available o…
- Announcement2026-08-11Viyash Scientific Limited announced approvals from its August 11, 2026 board meeting including unaudited Q1 FY2026 financial results, ESOP scheme allo…
- 🔴 Financial Results2026-08-11Viyash Scientific Limited reported Q1 FY27 consolidated revenues of ₹9,464 million, up 19.5% YoY, with EBITDA at ₹2,047 million (+59.2% YoY) and PAT a…
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-10-01.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when VIYASH files new disclosures
Track VIYASH filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track VIYASH — FreeFree account · 2 AI queries/day